Skip to main content

WELLS FARGO & COMPANY/MN

Position in OVID — Ovid Therapeutics Inc.

CIK 72971 SAN FRANCISCO, CA

Position in OVID

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,222,493
+$638,246 QoQ
Shares Held
826,206
+15.8% QoQ
Ownership
0.423%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 130 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 94% Shared 0% None 6%

Common Shares in OVID Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,567,775,023 across 417 Biotechnology names. OVID ranks #92 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in OVID

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,222,493 826,206
2026-03-31 $1,584,247 713,625
2025-12-31 $1,174,982 720,848
2025-09-30 $949,930 730,716
2025-06-30 $251,826 763,114
2025-03-31 $245,402 786,547
2024-12-31 $694,714 743,807
2024-09-30 $867,518 735,185
2024-06-30 $570,320 741,640
2024-03-31 $1,323,309 433,872
2023-12-31 $1,444,462 448,591
2023-09-30 $1,708,668 444,966
2023-06-30 $1,479,171 450,967
2023-03-31 $1,111,105 430,661
2022-12-31 $798,229 429,156
2022-09-30 $800,068 434,820
2022-06-30 $928,801 432,001
2022-03-31 $1,365,438 434,853
2021-12-31 $1,452,098 452,367
2021-09-30 $1,525,833 454,117
2021-06-30 $1,773,642 453,617
2021-03-31 $1,842,305 458,285
2020-12-31 $1,274,562 551,759
2020-09-30 $3,071,392 535,086
2020-06-30 $3,835,605 520,435
2020-03-31 $1,459,666 489,821